Safe delivery of systemic anti-cancer treatment for skin cancers during the COVID-19 pandemic

J Eur Acad Dermatol Venereol. 2023 Jan;37(1):e13-e16. doi: 10.1111/jdv.18514. Epub 2022 Aug 24.

Authors

Maria Jose Monroy-Iglesias¹, Hajer Hadi¹, Beth Russell¹, Charlotte Moss¹, Lucy Flanders², Saoirse Dolly², Sophie Papa², Mieke Van Hemelrijck¹

Affiliations

¹ King's College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology & Urology Research (TOUR), London, UK.
² Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK.

No abstract available

Publication types

Letter

MeSH terms

COVID-19*
Humans
Pandemics
SARS-CoV-2
Skin Neoplasms* / drug therapy
Skin Neoplasms* / epidemiology